APA

Vasmatzis G., Wang X., Smadbeck J. B., Murphy S. J., Geiersbach K. B., Johnson S. H., Gaitatzes A. G., Asmann Y. W., Kosari F., Borad M. J., Serie D. J., McLaughlin S. A., Kachergus J. M., Necela B. M. & Thompson E. A. (20190208). Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2. : BMC cancer.

Chicago

Vasmatzis George, Wang Xue, Smadbeck James B, Murphy Stephen J, Geiersbach Katherine B, Johnson Sarah H, Gaitatzes Athanasios G, Asmann Yan W, Kosari Farhad, Borad Mitesh J, Serie Daniel J, McLaughlin Sarah A, Kachergus Jennifer M, Necela Brian M and Thompson E Aubrey. 20190208. Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2. : BMC cancer.

Harvard

Vasmatzis G., Wang X., Smadbeck J. B., Murphy S. J., Geiersbach K. B., Johnson S. H., Gaitatzes A. G., Asmann Y. W., Kosari F., Borad M. J., Serie D. J., McLaughlin S. A., Kachergus J. M., Necela B. M. and Thompson E. A. (20190208). Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2. : BMC cancer.

MLA

Vasmatzis George, Wang Xue, Smadbeck James B, Murphy Stephen J, Geiersbach Katherine B, Johnson Sarah H, Gaitatzes Athanasios G, Asmann Yan W, Kosari Farhad, Borad Mitesh J, Serie Daniel J, McLaughlin Sarah A, Kachergus Jennifer M, Necela Brian M and Thompson E Aubrey. Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2. : BMC cancer. 20190208.